Literature DB >> 11108977

Application of microdialysis to characterize drug disposition in tumors.

J Chu1, J M Gallo.   

Abstract

Microdialysis is an in vivo sampling technique that was initially developed to measure endogenous substances in the field of neurotransmitter research. In the past decade, microdialysis has been increasingly applied to study the pharmacokinetics and drug metabolism in the blood and various tissues of both animals and humans. This paper describes the general aspects of this in vivo sampling technique followed by the survey of the recent papers regarding the application of microdialysis to characterize anticancer drug disposition in solid tumors. It can be concluded that microdialysis is a very suitable method to obtain drug concentration-time profiles in the interstitial fluid of solid tumors as well as of other variety of tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108977     DOI: 10.1016/s0169-409x(00)00115-0

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  10 in total

1.  Spinal disposition and meningeal permeability of local anesthetics.

Authors:  Rozenn Clément; Jean-Marc Malinovsky; Patrice Hildgen; Gilles Dollo; Jean Pierre Estèbe; François Chevanne; Roger Le Verge; Pascal Le Corre
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 2.  Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development.

Authors:  Jaishri Blakeley; Jana Portnow
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10-23       Impact factor: 4.481

Review 3.  In vivo microdialysis for PK and PD studies of anticancer drugs.

Authors:  Qingyu Zhou; James M Gallo
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

4.  A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas.

Authors:  Jana Portnow; Behnam Badie; Susan Markel; An Liu; Massimo D'Apuzzo; Paul Frankel; Rahul Jandial; Timothy W Synold
Journal:  Eur J Cancer       Date:  2013-02-04       Impact factor: 9.162

5.  Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate.

Authors:  Mingxin Qian; Wanda West; Jing-Tao Wu; Bing Lu; David D Christ
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

6.  Interstitial fluid: the overlooked component of the tumor microenvironment?

Authors:  Helge Wiig; Olav Tenstad; Per Ole Iversen; Raghu Kalluri; Rolf Bjerkvig
Journal:  Fibrogenesis Tissue Repair       Date:  2010-07-23

Review 7.  Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Authors:  Duhyeong Hwang; Jacob D Ramsey; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2020-09-24       Impact factor: 15.470

8.  Population Pharmacokinetic Modeling of Etoposide Free Concentrations in Solid Tumor.

Authors:  Maiara Cássia Pigatto; Bibiana Verlindo de Araujo; Bruna Gaelzer Silva Torres; Stephan Schmidt; Paolo Magni; Teresa Dalla Costa
Journal:  Pharm Res       Date:  2016-04-11       Impact factor: 4.200

9.  The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation.

Authors:  Jana Portnow; Behnam Badie; Mike Chen; An Liu; Suzette Blanchard; Timothy W Synold
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

Review 10.  Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology.

Authors:  Tony K L Kiang; Sahan A Ranamukhaarachchi; Mary H H Ensom
Journal:  Pharmaceutics       Date:  2017-10-11       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.